Chemodex

5-Hydroxy-L-tryptophan

CHF 27.00
In stock
CDX-H0160-G0011 gCHF 27.00
CDX-H0160-G0055 gCHF 108.00
CDX-H0160-G02525 gCHF 434.00
More Information
Product Details
Synonyms Oxitriptan; 5-HTP; L-2-Amino-3-(5-hydroxyindolyl)propionic acid; L-5-HTTP; L-5-Hydroxytryptophan
Product Type Chemical
Properties
Formula

C11H12N2O3

MW 220.22
CAS 4350-09-8
RTECS YN7110000
Source/Host Chemicals Isolated from plant source.
Purity Chemicals ≥99% (HPLC)
Appearance Off-white powder.
Solubility Soluble in water, chloroform or DMSO.
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key LDCYZAJDBXYCGN-VIFPVBQESA-N
Smiles OC1=CC=C(NC=C2C[C@H](N)C(O)=O)C2=C1
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage +4°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at +4°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

5-hydroxy-L-Tryptophan (5-HTP), also known as oxitriptan, is a naturally occurring amino acid and chemical precursor as well as a metabolic intermediate in the biosynthesis of the neurotransmitter serotonin. It is used as a dietary supplement for use as an antidepressant, appetite suppressant, and sleep aid. It is also used as L-aromatic amino acid decarboxylase substrate. When injected systemically in animals, 5-HTP is converted to serotonin and has both peripheral and central nervous system effects. 5-HTP can also be synthesized by gut microbiota and acts as an activator of the aryl hydrocarbon receptor.

Product References

(1) A. Carlsson, et al.; Nature 180, 1200 (1957) | (2) A. Boiardi, et al.; J. Neurol. 225, 41 (1981) | (3) T.C. Birdsall; Altern. Med. Rev. 3, 271 (1998)| (4) A. Martinez, et al.; Curr. Med. Chem. 8, 1077 (2001) | (5) E.H. Turner, et al.; Pharmacol. Ther. 109, 325 (2006) | (6) C.L. Schmid & L.M. Bohn; J. Neurosci. 30, 13513 (2010) | (7) G.V. Sridharan, et al.; Nat. Commun. 5, 5492 (2014) | (8) R. Haberzettl, et al.; Behav. Brain Res. 277, 204 (2015) | (9) J.-A. Mora-Villalobos & A.-P. Zeng; J. Biol. Eng. 12, 3 (2018)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.